CoChat

Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes

Open access
Brouwers, Bram, Schrauwen-Hinderling, Vera B., Jelenik, Tomas, Gemmink, Anne, Havekes, Bas, Bruls, Yvonne, Dahlmans, Dennis, Roden, Michael, Hesselink, Matthijs K.C., Schrauwen, Patrick · 2017 · Clinical Science

The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.

Abstract

Non-alcoholic fatty liver (NAFL) is an independent risk factor for the development of type 2 diabetes (T2DM). We examined metabolic perturbations in patients with NAFL, patients with T2DM, and control (CON) subjects with normal intrahepatic lipid (IHL) content. A two-step (10 mU/m2 /min; 40 mU/m2/min) hyperinsulinemic–euglycemic clamp was performed in 11 NAFL, 13 T2DM, and 11 CON subjects, all matched for BMI, and aerobic fitness. IHL content was measured using proton magnetic resonance spectroscopy. Because of high IHL content variability in T2DM patients, this group was separated into a high IHL content group (IHL ≥ 5.0%, T2DM+NAFL) and a normal IHL content group (IHL < 5.0%, T2DM-non-NAFL) for further analysis. IHL content was increased in NAFL and T2DM+NAFL subjects (P<0.050 versus CON and T2DM-non-NAFL subjects). Adipose tissue insulin sensitivity index (Adipo-IRi) was higher in NAFL (P<0.050 versus CON and T2DM-non-NAFL subjects) and in T2DM+NAFL subjects (P=0.055 versus CON subjects, P<0.050 versus T2DM-non-NAFL subjects). Suppression of plasma-free fatty acids (P=0.046) was lower in NAFL compared with CON subjects, with intermediate values for T2DM-non-NAFL, and T2DM+NAFL subjects. Suppression of endogenous glucose production (EGP) and insulin-stimulated glucose disposal (ΔRd) was comparable between NAFL, T2DM-non-NAFL, and T2DM+NAFL subjects (all P>0.05), and was lower in comparison with CON subjects (all P<0.01). Metabolic flexibility was lower in T2DM-non-NAFL subjects (P=0.047) and NAFL subjects (P=0.059) compared with CON subjects. Adipo-IRi (r=0.652, P<0.001), hepatic insulin resistance index (HIRi) (r=0.576, P=0.001), and ΔRd (r=−0.653, P<0.001) correlated with IHL content. Individuals with NAFL suffer from metabolic perturbations to a similar degree as T2DM patients. NAFL is an important feature leading to severe insulin resistance and should be viewed as a serious health threat for the development of T2DM. ClinicalTrials.gov: NCT01317576

Overview

Integrity signals

Registry

Crossref · 10.1042/cs20170261

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 50 references

Research works printed but not linked: 1

  1. Roden, 2006, Mechanisms of Disease: hepatic steatosis in type 2 diabetes–pathogenesis and clinical relevance. Nature clinical practice, Endocrinol. Metab., 2, 335

Cited by

See all 60

Metadata

Authors
Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., & Schrauwen, P.
Affiliations
  • Maastricht University Medical Centre (NL)
  • NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands
  • Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University Düsseldorf, Düsseldorf, Germany
  • Deutsches Diabetes-Zentrum e.V. (DE)
Corresponding author
Schrauwen, Patrick
Venue
Clinical Science
Published
2017-07-07
Volume
131
Issue
15
Pages
1905-1917
ISSN
  • 0143-5221 (ISSN-L)
  • 1470-8736
OpenAlex
W2626282634
Cited by
59
References
52
Citations by year
2026: 3 · 2025: 8 · 2024: 4 · 2023: 8 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 4
FWCI
4.91
Type
journal article
Language
en
Licence
other-oa
Locations
  • Clinical Science (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (acceptedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • Deutsche Forschungsgemeinschaft (SFB 1116)
  • Diabetes Fonds (2009.60.003)
  • Maastricht Universitair Medisch Centrum
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
non-alcoholic fatty liver disease, type 2 diabetes, insulin resistance, hepatic insulin resistance, metabolic flexibility, hyperinsulinemic-euglycemic clamp, intrahepatic lipid, adipose tissue insulin sensitivity, free fatty acids, endogenous glucose production, glucose disposal, hepatic glucose production, hepatic lipogenesis, hepatic de novo lipogenesis, hepatic glucose uptake
MeSH terms
Adipose Tissue, Adult, Aged, Body Composition, Diabetes Mellitus, Type 2, Humans, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Magnetic Resonance Spectroscopy, Glucose Clamp Technique, Muscle, Skeletal, Lipid Metabolism, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes. https://app.cochat.ai/papers/10.1042/cs20170261
The paper
Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., & Schrauwen, P. (2017). Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes. Clinical Science. https://doi.org/10.1042/cs20170261

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.